Full Text
PMS11 INFLIXIMAB COSTS AND REASONS FOR TREATMENT DISCONTINUATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TREATMENT IN U.S. HOSPITALS: 2012-2015

Abstract

Authors

N. Rosenthal D. Wu C. Arsever A. Kartashov D. Baumer

Back to Volume 22, Supplemental S2
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×